Skip to main content
. 2024 Aug 7;18:17534666241266343. doi: 10.1177/17534666241266343

Figure 2.

Figure 2.

Course of FVC decline in the INPULSIS trials in patients with IPF and the INBUILD trial in patients with progressive fibrosing ILDs other than IPF. 8

Source: Brown et al. 8 Reproduced with permission of the © ERS 2023.

IPF, idiopathic pulmonary fibrosis; ILDs, interstitial lung diseases.